Cargando…
Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
The ability to efficiently deliver a drug or gene to a tumor site is dependent on a wide range of factors including circulation time, interactions with the mononuclear phagocyte system, extravasation from circulation at the tumor site, targeting strategy, release from the delivery vehicle, and uptak...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142601/ https://www.ncbi.nlm.nih.gov/pubmed/25202689 http://dx.doi.org/10.3389/fchem.2014.00069 |